IDEX Biometrics ASA
IDBA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $4,152 | $4,092 | $2,840 | $1,095 |
| % Growth | 1.5% | 44.1% | 159.4% | – |
| Cost of Goods Sold | $3,920 | $3,244 | $1,254 | $275 |
| Gross Profit | $232 | $848 | $1,586 | $820 |
| % Margin | 5.6% | 20.7% | 55.8% | 74.9% |
| R&D Expenses | $3,648 | $3,250 | $2,680 | $1,895 |
| G&A Expenses | $0 | $19,213 | $21,107 | $20,578 |
| SG&A Expenses | $14,350 | $19,213 | $21,107 | $21,342 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $764 |
| Other Operating Expenses | $9,166 | $9,754 | $9,149 | $3,985 |
| Operating Expenses | $27,164 | $32,217 | $32,936 | $27,222 |
| Operating Income | -$26,932 | -$31,369 | -$31,350 | -$26,402 |
| % Margin | -648.6% | -766.6% | -1,103.9% | -2,411.1% |
| Other Income/Exp. Net | -$243,622 | -$1,329 | -$1,112 | -$451 |
| Pre-Tax Income | -$270,554 | -$32,698 | -$32,462 | -$26,853 |
| Tax Expense | -$16 | -$36 | $90 | -$99 |
| Net Income | -$26,713 | -$32,660 | -$32,550 | -$26,750 |
| % Margin | -643.4% | -798.1% | -1,146.1% | -2,442.9% |
| EPS | -1.07 | -0.15 | -0.2 | -0.15 |
| % Growth | -613.3% | 25% | -33.3% | – |
| EPS Diluted | -1.07 | -0.15 | -0.2 | -0.15 |
| Weighted Avg Shares Out | 253,043 | 205,390 | 183,770 | 153,410 |
| Weighted Avg Shares Out Dil | 253,042 | 206,400 | 188,090 | 154,680 |
| Supplemental Information | – | – | – | – |
| Interest Income | $879 | $97 | $11 | $26 |
| Interest Expense | $667 | $33 | $31 | $477 |
| Depreciation & Amortization | $1,028 | $13,007 | $15,495 | $16,182 |
| EBITDA | -$273,857 | -$29,921 | -$29,537 | -$24,657 |
| % Margin | -6,595.7% | -731.2% | -1,040% | -2,251.8% |